Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON Adds Experts to Global Scientific Council | Contract Pharma

What are you searching for?

Sign in
Breaking News

ICON Adds Experts to Global Scientific Council

Buckley and Alp to expand scientific expertise

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Professor Brendan Buckley has been appointed senior vice president, Medical Affairs at ICON. He joined the company in July 2011 through the company’s acquisition of Firecrest Clinical. He is an endocrinologist with more than 30 years of experience and is Honorary Professor of Medicine and Pharmacology at the School of Medicine, University College Cork (UCC), Ireland.

Dr. Nicholas Alp has been appointed vice president and Therapeutic Area Leader for Cardiovascular, based in Marlow, UK. Prior to joining ICON, Dr. Alp held senior appointments in Cardiovascular Medicine at Oxford University, and as a consultant interventional cardiologist at Oxford Radcliffe Hospitals NHS Trust. He has more than 17 years of clinical research experience and has developed substantial insight into clinical trial design, research ethics and regulatory processes.

Both Professor Buckley and Dr. Alp have been appointed to ICON’s Global Scientific Council, a team of experts with broad industry experience of the scientific, technical and therapeutic aspects of product development.

“We are delighted to welcome Professor Buckley and Dr. Alp to the Global Scientific Council,” said Jonathan Goldman, executive vice president, Strategic Development at ICON. “Their expertise will be an invaluable resource to help sponsors shape their product development strategies and they will also offer strong guidance to ICON study teams. These appointments are part of ICON’s ongoing commitment to strengthen and expand its scientific expertise to provide clients with a fully integrated, strategic development service.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics